Biological influence of Hakai in cancer: a 10-year review
Open Access
- 19 February 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 31 (1-2), 375-386
- https://doi.org/10.1007/s10555-012-9348-x
Abstract
In order to metastasize, cancer cells must first detach from the primary tumor, migrate, invade through tissues, and attach to a second site. Hakai was discovered as an E3 ubiquitin-ligase that mediates the posttranslational downregulation of E-cadherin, a major component of adherens junctions in epithelial cells that is characterized as a potent tumor suppressor and is modulated during various processes including epithelial–mesenchymal transition. Recent data have provided evidences for novel biological functional role of Hakai during tumor progression and other diseases. Here, we will review the knowledge that has been accumulated since Hakai discovery 10 years ago and its implication in human cancer disease. We will highlight the different signaling pathways leading to the influence on Hakai and suggest its potential usefulness as therapeutic target for cancer.Keywords
This publication has 108 references indexed in Scilit:
- Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherinThe EMBO Journal, 2012
- RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisNature Reviews Cancer, 2011
- Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesisCell Research, 2011
- Novel Roles of Hakai in Cell Proliferation and OncogenesisMolecular Biology of the Cell, 2009
- RNA interference screen for human genes associated with West Nile virus infectionNature, 2008
- Catenins: Keeping Cells from Getting Their Signals CrossedDevelopmental Cell, 2006
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migrationThe EMBO Journal, 2001
- The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factorsNature, 2001
- The Hallmarks of CancerCell, 2000